GW&K Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-116
| Closed | -$18K | – | 511 |
|
|
2022
Q3 | $18K | Sell |
116
-776
| -87% | -$120K | ﹤0.01% | 345 |
|
|
2022
Q2 | $130K | Sell |
892
-405,364
| -100% | -$59.1M | ﹤0.01% | 348 |
|
|
2022
Q1 | $48.2M | Buy |
406,256
+25,819
| +7% | +$3.06M | 0.43% | 92 |
|
|
2021
Q4 | $52.4M | Buy |
380,437
+302,679
| +389% | +$41.7M | 0.44% | 92 |
|
|
2021
Q3 | $10.8M | Sell |
77,758
-25,606
| -25% | -$3.56M | 0.1% | 215 |
|
|
2021
Q2 | $10M | Sell |
103,364
-2,348
| -2% | -$228K | 0.09% | 220 |
|
|
2021
Q1 | $7.23M | Buy |
105,712
+4,600
| +5% | +$314K | 0.07% | 238 |
|
|
2020
Q4 | $8.67M | Sell |
101,112
-18,228
| -15% | -$1.56M | 0.09% | 223 |
|
|
2020
Q3 | $7.76M | Buy |
119,340
+23,299
| +24% | +$1.51M | 0.1% | 223 |
|
|
2020
Q2 | $7.02M | Sell |
96,041
-35,996
| -27% | -$2.63M | 0.1% | 220 |
|
|
2020
Q1 | $4.49M | Sell |
132,037
-8,009
| -6% | -$273K | 0.08% | 223 |
|
|
2019
Q4 | $7.62M | Sell |
140,046
-6,330
| -4% | -$345K | 0.1% | 217 |
|
|
2019
Q3 | $6.11M | Buy |
146,376
+42,896
| +41% | +$1.79M | 0.09% | 222 |
|
|
2019
Q2 | $4.53M | Sell |
103,480
-1,199
| -1% | -$52.5K | 0.07% | 251 |
|
|
2019
Q1 | $5.39M | Sell |
104,679
-16,627
| -14% | -$856K | 0.09% | 218 |
|
|
2018
Q4 | $4.49M | Buy |
+121,306
| New | +$4.49M | 0.09% | 206 |
|